Imipenem and Cilastatin - Sodium 250 mg / 20mL; 250 mg / 20mL Injection 20 mL
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 63323-0349-25 |
|---|---|
| Product NDC | 63323-0349 |
| Generic Drug Name | Imipenem and Cilastatin Sodium |
| Brand Name | Imipenem and Cilastatin |
| Manufacturer | Fresenius Kabi USA, LLC |
| Strength | 250 mg / 20mL; 250 mg / 20mL |
| Dosage Form | Injection |
| Drug Type | Intravenous |
| Package Quantity | 25 Vial, Single-Dose |
| Package Description | 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-349-25) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-349-01) |
| Active Ingredients | Cilastatin Sodium; Imipenem |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Imipenem and Cilastatin Sodium 250 mg / 20mL; 250 mg / 20mL Injection is tracked under NDC 63323-0349-25 and rolls up into product family 63323-0349. Use this page to confirm the exact presentation before comparing related family pages or starting a quote review.
- Package configuration: 25 Vial, Single-Dose.
- Manufacturer: Fresenius Kabi USA, LLC.
- Dosage form: Injection.
- Family size: 3 indexed presentations.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby exact-item pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Drug Shortage Information
Drug Shortage Index family
View Imipenem and Cilastatin Sodium in the Drug Shortage IndexCompare related exact NDC products and family-level shortage context for Imipenem and Cilastatin Sodium.Source: Public FDA drug shortage records accessed through FDA-owned openFDA drug shortages queries.
This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Imipenem and Cilastatin - Sodium 250 mg / 20mL; 250 mg / 20mL Injection 20 mL, NDC 63323-0349-25, is a Fresenius Kabi USA, LLC 250 mg / 20mL; 250 mg / 20mL injection presentation packaged as 25 Vial, Single-Dose. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 63323-0349-25
- Digits-only NDC 11: 63323034925
- Possible 10-digit display format: 63323-349-25 (6332334925)
Helpful product links
- Search by brand name: Imipenem and Cilastatin
- Exact NDC 11: 63323-0349-25
- Product family NDC: 63323-0349
- Compare related presentations: Imipenem and Cilastatin - Sodium 250 mg / 20mL; 250 mg / 20mL Injection 20 mL, Imipenem and Cilastatin - Sodium 250 mg / 20mL; 250 mg / 20mL Injection 20 mL
- VA classification code: AM119
- VA classification code description: BETA-LACTAMS ANTIMICROBIALS,OTHER
- CMOP ID: C1399
- VUID: 4002992
- UNSPSC code: 51284903
- Misc. Order Numbers: 1013391